C. Haworth (Cambridge, United Kingdom), P. Goeminne (Bornem, Belgium)
Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
M. Schuurbiers (Nijmegen, Netherlands), M. Bruno (Nijmegen, Netherlands), S. Zweijpfenning (Nijmegen, Netherlands), M. Netea (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), F. Van De Veerdonk (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands)
|   |
Switch effects from daily to intermittent treatment with a daily regimen dosage for Mycobacterium avium complex pulmonary disease
M. Matsumoto (Ono, Japan), K. Masuda (Ono, Japan), K. Kaneshiro (Ono, Japan), K. Takatsuki (Ono, Japan)
| |
Non-tuberculous mycobacteria management in adult patients with Cystic Fibrosis: a retrospective study
J. Mencarini (Florence, Italy), S. Bresci (Florence, Italy), B. Borchi (Florence, Italy), A. Cavallo (Florence, Italy), R. Guarise (Florence, Italy), F. Bartalesi (Florence, Italy), A. Bartoloni (Florence, Italy)
| |
Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.
Y. Vande Weygaerde (Ghent, Belgium), N. Cardinaels (Leuven, Belgium), P. Bomans (Antwerp, Belgium), T. Chin (Ghent, Belgium), E. Van Braeckel (Ghent, Belgium), N. Lorent (Leuven, Belgium)
| |
Pulmonary non-tuberculous mycobacterial infection: 889 cases
A. Babalik (ISTANBUL, Turkey), T. Kuyucu (ISTANBUL, Turkey), F. Kutluhan (ISTANBUL, Turkey), H. Isik (ISTANBUL, Turkey), E. Koç (ISTANBUL, Turkey), G. Dönmez (ISTANBUL, Turkey), E. Ordu (ISTANBUL, Turkey), A. Balikçi (ISTANBUL, Turkey), O. Köksalan (ISTANBUL, Turkey)
| |
Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease
Y. Park (Seoul, Republic of Korea), O. Kim (Seoul, Republic of Korea), B. Kwon (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea)
| |
Lung function evolution in patients with microbiological isolation of Mycobacterium abscessus
P. Mariscal Aguilar (Madrid, Spain), D. Laorden Escudero (Madrid, Spain), A. Giménez Velando (Madrid, Spain), S. Quirós Fernández (Madrid, Spain), C. Carpio Segura (Madrid, Spain), R. Girón Moreno (Madrid, Spain), C. Toro Rueda (Madrid, Spain), J. Esteban Moreno (Madrid, Spain), C. Prados Sánchez (Madrid, Spain), R. Álvarez-Sala Walther (Madrid, Spain)
| |
Mucoid Pseudomonas aeruginosa alter sputum viscoelastic properties in patients with non-cystic fibrosis bronchiectasis
V. Alcaraz Serrano (Barcelona, Spain), L. Fernandez Barat (Barcelona, Spain), G. Scioscia (Barcelona, Spain), J. Llorens Llacuna (Barcelona, Spain), E. Gimeno Santos (Barcelona, Spain), B. Herrero Cortina (Barcelona, Spain), N. Vazquez (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), R. Amaro Rodriguez (Barcelona, Spain), R. Menendez (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Risk factors for new P. aeruginosa isolation in bronchiectasis- data from the European Bronchiectasis Registry (EMBARC)
P. Burgel (Paris, France), E. Polverino (Barcelona, Spain), C. Harworth (Cambridge, United Kingdom), M. Murris-Espin (Toulouse, France), K. Dimakou (Athensrcelona, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milano, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), J. Elborn (Belfast, United Kingdom), S. Aliberti (Milano, Italy), P. Goeminne (Leuven, Belgium)
| |
S. pneumoniae prevalence and serotypes in sputum of stable bronchiectasis
S. Aliberti (Milan, Italy), L. Terranova (Milan, Italy), M. Oriano (Milan, Italy), G. Sotgiu (Sassari, Italy), E. Franceschi (Milan, Italy), A. Gramegna (Milan, Italy), L. Ruggiero (Milan, Italy), L. Saderi (Sassari, Italy), C. Di Francesco (Milan, Italy), A. Gelmini (Milan, Italy), E. Simonetta (Milan, Italy), S. Ferri (Milan, Italy), F. Amati (Milan, Italy), A. Colombo (Milan, Italy), P. Marchisio (Milan, Italy), F. Blasi (Milan, Italy)
| |
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
I. Laska (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Real time polymerase chain reaction versus conventional culture method to detect respiratory pathogens in subjects with non-cystic fibrosis bronchiectasis.
B. PITSO (PRETORIA, South Africa), R. Green (PRETORIA, South Africa), R. Masekela (PRETORIA, South Africa), G. Ameena (PRETORIA, South Africa)
| |
Characterisation of sputum pregnancy zone protein in bronchiectasis
S. Finch (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), T. Fardon (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Platelet activation correlates with disease severity in bronchiectasis
R. Méndez (Valencia, Spain), A. Moscardó (Valencia, Spain), A. Latorre (Valencia, Spain), A. Piró (Valencia, Spain), P. Gonzalez-Jimenez (Valencia, Spain), L. Feced (Valencia, Spain), L. Bouzas (Valencia, Spain), R. Amaro (Barcelona, Spain), V. Alcaraz (Barcelona, Spain), A. Torres (Barcelona, Spain), R. Menéndez (Valencia, Spain)
| |
Profitability of sputum culture of samples classified as "not valid" by the criteria of Murray and Washington in patients with non-cystic fibrosis bronchiectasis.
S. Dominguez Pazos (A Coruña, Spain), M. Blanco Aparicio (A Coruña, Spain), B. Fernández Pérez (A Coruña, Spain), M. González Bardanca (A Coruña, Spain), M. Fernández Marrube (A Coruña, Spain), E. Elguezabal Bilbao (A Coruña, Spain), F. Méndez Salazar (A Coruña, Spain), G. Bou Arévalo (A Coruña, Spain), C. Montero Martínez (A Coruña, Spain)
| |
Inflammatory molecular endotypes in bronchiectasis
A. Shoemark (Dundee, United Kingdom), A. Smith (Dundee, United Kingdom), A. Giam (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom)
| |
Respiratory viruses in stable state bronchiectasis
A. Gramegna (Milan, Italy), S. Aliberti (Milan, Italy), S. Zucchetti (Milan, Italy), E. Simonetta (Milan, Italy), D. Castelli (Milan, Italy), A. Cavallero (Milan, Italy), V. Conio (Milan, Italy), A. Grosso (Milan, Italy), P. Faverio (Milan, Italy), D. Radovanovic (Milan, Italy), S. Terraneo (Milan, Italy), F. Di Marco (Milan, Italy), A. Pesci (Milan, Italy), C. Airoldi (Milan, Italy), V. Valenti (Milan, Italy), A. Corsico (Milan, Italy), P. Santus (Milan, Italy), S. Centanni (Milan, Italy), F. Blasi (Milan, Italy)
| |
Heparin Binding Protein in sputum compromises epithelial defence and relates to bronchiectasis severity
A. Smith (Dundee, United Kingdom), J. Lang (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), A. Shoemark (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |